The incidence of peripheral oedema was lower in the vildagliptin group than in the rosiglitazone group (2.1% vs.
A perifériás ödéma incidenciája alacsonyabb volt a vildagliptin -, mint a roziglitazon- csoportban (sorrendben 2, 1% vs.